drugset / Trial / NCT02208791

Effects of the Quadruple Immunosuppression on Peripheral Blood Lymphocytes and Development of Anti-HLA Antibodies in Kidney Transplant

NCT02208791

Phase 4 Unknown 45 enrolled University of Sao Paulo General Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the effects of sirolimus in the phenotype of peripheral blood T and B lymphocytes regarding their naïve, memory, effector end regulatory phenotype and in the development of anti-HLA antibodies among kidney transplant recipients with high immunological risk for graft rejection.

Timeline

Start
2014-07
Primary completion
2016-07
Completion
2017-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Sirolimus Small molecule 2 mg

Indications

No indication recorded.